---
title: "Estimating AE risk under varying follow-up times and competing risks"
author: "Lu Mao, KyungMann Kim"
date: today
format: 
  html:
   toc: true
---

## Existing materials

#### ISCB (2024) Invited Session

*Quantification of safety signals in clinical trials: Estimand, estimation, and how would good look like in ten years?* \[[Abstracts](References/abstracts.pdf){target="_blank"}\]

-   **Kaspar Rufibach**: Principled approach to time-to-event endpoints with competing risks, with a focus on analysis of aes \[[slides](References/Rufibach_slides_2023.pdf){target="_blank"}\]
-   **Anja Loos**: Estimands for safety â€“ one size fits all? \[[paper](References/Unkel et al (2019) - Pharm Statist.pdf){target="_blank"}\]
-   **Laura Antolini**: Adverse events with survival outcomes: from clinical questions to methods for statistical analysis \[[PhD dissertation](References/ELENA_phd.pdf){target="_blank"}\]
-   **Kit Roes**: Regulatory perspective on the analysis of safety in clinical trials and beyond \[slides\]

SAVVY site: [https://numbersman77.github.io/savvy/](https://numbersman77.github.io/savvy/){target="_blank"}.

### Literature review


## *While-on-treatment* approach

```{r}

```
